Guest guest Posted January 6, 2006 Report Share Posted January 6, 2006 on Fri, Jan. 06, 2006 Coroner rules autistic boy died from controversial therapy Associated Press MONROEVILLE, Pa. - An autistic boy died as a result of a controversial treatment known as chelation, a coroner ruled, but it wasn't clear whether an inquest will be held to determine if criminal charges are warranted. Abubakar Nadama, 5, of Monroeville, went into cardiac arrest in his doctor's office in Portersville, County, after the intravenous chelation therapy Aug. 23. Chelation therapy involves injecting a synthetic amino acid called EDTA into the body, which is supposed to clean out heavy metals from the bloodstream so they can be dispelled through urine. The FDA has approved chelation for treatment of lead and heavy metal poisoning, but not to treat autism - which some parents and doctors believe is caused by heavy metals - because it is considered risky. Ed Strimian, a deputy coroner Allegheny County who performed the autopsy for County Coroner Young, said toxicology tests confirmed the treatment killed the boy. " We determined there's a direct correlation between the EDTA and the lack of oxygen to the brain and the heart and muscle damage, " Strimian told the Pittsburgh Post-Gazette for Friday's editions. Nobody has been charged in the boy's death. Rufia and Mawra Nadama, the boy's parents are from Nigeria but moved to England 10 years ago. Mawra Nadama and her son then moved to the Pittsburgh suburb of Monroeville last spring few months ago so the boy could receive the chelation treatment, the couple's attorney, Botta has said. The Nadamas do not have a telephone listed in their name. Botta didn't immediately return a call for comment Friday. Young said he plans to meet soon with District Attorney Randa and the state police to determine if an inquest is warranted. For now, Young is classifying the death as an accident, but said that could change if more information is uncovered through the inquest or other investigation. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.